Research Endpoints will manage the growing demand for the Scottsdale, Arizona-based firm's imaging research and biomarker business, according to an announcement made Wednesday.

The move comes after the Senate recently passed a fix to address the 2% Medicare sequester reduction set to take hold April 1. 

An AI system for diagnosing prostate cancer on biopsy slides has achieved 98%-plus performance in sensitivity, positive predictive value, specificity and negative predictive value.

Growing imaging workloads and clear patient benefits should encourage rads to see this as an opportunity rather than a turf threat, two experts argued in a new editorial.

“One year into the COVID-19 pandemic, we already see the consequences of pandemic-driven drops in cancer screening and diagnostics," ASTRO Chair Thomas Eichler, MD, said.

The FDA is alerting patients who have received breast imaging services from Tennessee Women’s Care amid concerns about its safety practices. 

As part of the change, the El Segundo, California-based imaging giant promoted 13 of its top physicians to serve in new leadership roles. 

Two healthcare heavyweights are combining forces to form a technology center they hope will, over the next 10 years, “fundamentally advance the pace” of discovery in medical science and healthcare innovation.